Ahmad Usman, Yang Haoxian, Sima Camelia, Buitrago Daniel H, Ripley R Taylor, Suzuki Kei, Bains Manjit S, Rizk Nabil P, Rusch Valerie W, Huang James, Adusumilli Prasad S, Rocco Gaetano, Jones David R
Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou City, Guangdong Province, China.
Ann Thorac Surg. 2015 Jul;100(1):215-21; discussion 221-2. doi: 10.1016/j.athoracsur.2015.03.013. Epub 2015 May 20.
We sought to determine the prognostic variables associated with overall survival (OS) and recurrence-free probability (RFP) in patients with primary and secondary sternal tumors treated with surgical resection.
A retrospective analysis of patients who underwent resection of primary or secondary sternal tumors at 2 cancer institutes between 1995 and 2013 was performed. OS and RFP were estimated using the Kaplan-Meier method, and predictors of OS and RFP were analyzed using the Cox proportional hazards model.
Sternal resection was performed in 78 patients with curative (67 [86%]) or palliative (6 [8%]) intent. Seventy-three patients (94%) had malignant tumors, of which 28 (36%) were primary and 45 (57%) were secondary malignancies. Sternal resections were complete in 13 patients (17%) and partial in 65 (83%). There were no perioperative deaths, and grade III/IV complications were noted in 17 patients (22%). The 5-year OS was 80% for patients with primary malignant tumors, 73% for patients with nonbreast secondary malignant tumors, and 58% for patients with breast tumors (p = 0.85). In the overall cohort, R0 resection was associated with prolonged 5-year OS (84% vs 20%) on univariate (p = 0.004) and multivariate (adjusted hazard ratio, 3.37; p = 0.029) analysis. On subgroup analysis, R0 resection was associated with improved OS and RFP only for patients with primary malignant tumors.
Sternal resection can achieve favorable OS for patients with primary and secondary sternal tumors. R0 resection is associated with improved 5-year OS and RFP in patients with primary malignant tumors. We did not detect a similar effect in patients with breast or nonbreast secondary tumors.
我们试图确定接受手术切除治疗的原发性和继发性胸骨肿瘤患者的总生存期(OS)和无复发生存概率(RFP)相关的预后变量。
对1995年至2013年间在2家癌症研究所接受原发性或继发性胸骨肿瘤切除术的患者进行回顾性分析。采用Kaplan-Meier法估计OS和RFP,并使用Cox比例风险模型分析OS和RFP的预测因素。
78例患者接受了胸骨切除术,其中根治性切除67例(86%),姑息性切除6例(8%)。73例(94%)患者患有恶性肿瘤,其中28例(36%)为原发性,45例(57%)为继发性恶性肿瘤。13例(17%)患者胸骨切除完整,65例(83%)患者胸骨切除部分。无围手术期死亡,17例(22%)患者出现Ⅲ/Ⅳ级并发症。原发性恶性肿瘤患者的5年总生存率为80%,非乳腺继发性恶性肿瘤患者为73%,乳腺肿瘤患者为58%(p = 0.85)。在整个队列中,单因素分析(p = 0.004)和多因素分析(调整后风险比,3.37;p = 0.029)显示,R0切除与5年总生存期延长相关(84%对20%)。亚组分析显示,仅原发性恶性肿瘤患者的R0切除与总生存期和无复发生存概率改善相关。
胸骨切除术可使原发性和继发性胸骨肿瘤患者获得良好的总生存期。R0切除与原发性恶性肿瘤患者5年总生存期和无复发生存概率改善相关。我们在乳腺或非乳腺继发性肿瘤患者中未发现类似效果。